In vitro Measured Indoleamine 2, 3-dioxygenase Activity Correlates with Inflammation and Tryptophan Levels In vivo
Journal Title: International Neuropsychiatric Disease Journal - Year 2014, Vol 2, Issue 5
Abstract
Aims: To evaluate the diagnostic validity of an in vitro assay for indoleamine 2,3-dioxygenase (IDO) activity as indicator for biological alterations that are associated with depressive symptomatologies. Study Design: Retrospective evaluation of a medical database. Place and Duration of Study: Institute for Medical Diagnostics, Berlin, between April and July 2013. Methodology: We compared values for IDOin vitro, a so far unpublished assay for IDO activity that measures tryptophan degradation in peripheral blood monocytic cell (PBMC), with blood levels of tryptophan and tumor necrosis factor alpha (TNF-alpha). Values were derived from a clinical database comprising 441 patients who had received IDOin vitro, tryptophan and/or TNF-alpha testing in the course of medical treatment between May 2011 and March 2013. All data was anonymized. Clinical significance of IDOin vitro was evaluated by correlation of IDOin vitro to blood tryptophan and TNF-alpha α levels. Further, we challenged the validity of the IDOin vitro assay by investigating the influence of the PBMC proliferation rate as a potential confounding factor and comparing the responses to phythemagglutinin (PHA) and interferon-gamma (IFN-gamma), a recognized inducer of IDO activity. Results: Low plasma tryptophan and high serum TNF-alpha are associated with increased IDOin vitro (2.8±3.3 vs. 2.2±1.1, P=0.04 and 2.7±3.5 vs. 2.1±1.6, P=0.05). Elevated IDOin vitro is not due to increased PBMC proliferation rates. PHA and IFN-gamma yield correlating IDOin vitro values (correlation coefficient=0.91). Conclusions: IDOin vitro represents a valid diagnostic tool for IDO activity and correlates with inflammation and decreased availability of tryptophan in vivo. IDOin vitro may therefore serve as a biomarker to examine the interaction of inflammation and tryptophan metabolism that underlies a subgroup of depressive symptomatologies.
Authors and Affiliations
Katrin Huesker, Jana Schenk, Stefan Albrecht, Imad Lahdou, Volker von Baehr
Keywords
Related Articles
- EP ID EP241541
- DOI 10.9734/INDJ/2014/9065
- Views 129
- Downloads 0
Role of 3D FLAIR in Demonstration of Peripheral Lesions of Brainstem and Cranial Neuropathies
Aim: We present a pictorial review of 3D FLAIR images depicting its importance in demonstrating the peripheral lesions of brainstem particularly in relation to attachment of cranial nerves and cranial neuropathies and pa...
Mindfulness, Sexual Functioning, and Subjective Sexual Well-Being
Although there are several studies that address mindfulness, sexual functioning, and subjective sexual well-being separately, there are very few studies that explore the associations between these three constructs. There...
Cholinesterase Inhibitors in Non-age Related Neurodegenerative Dementias
Aims: Dementia is common among the elderly but it can also affect the younger age group. Cholinesterase inhibitors (ChEI) in Alzheimer Dementia (AD) are extensively studied and widely used. This case report aims to illus...
Medication Related Factors of Adherence and Attitude to Medication among Outpatients with Bipolar Disorder in Uyo, South-South Nigeria
A high level of medication adherence is required for effective treatment of bipolar disorder due to the chronic progressive nature of the illness requiring maintenance treatment. Aims: This study was conducted to determ...
Resveratrol Reduces C-reactive Protein and Cholesterol in Schizophrenia
Patients with schizophrenia (SZ) are generally found with overweight and obesity and several metabolic disorders. Additionally these patients have less life expectancy, with cardiovascular disease (CVD) the main cause of...